Medtronic plc Share Price

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
79.74 USD +0.62% Intraday chart for Medtronic plc +0.33% -3.20%
Sales 2024 * 32.24B 2,688B Sales 2025 * 33.57B 2,799B Capitalization 106B 8,828B
Net income 2024 * 4.55B 380B Net income 2025 * 5.24B 436B EV / Sales 2024 * 3.98 x
Net Debt 2024 * 22.3B 1,859B Net Debt 2025 * 21.07B 1,757B EV / Sales 2025 * 3.78 x
P/E ratio 2024 *
22.8 x
P/E ratio 2025 *
19.7 x
Employees 95,000
Yield 2024 *
3.45%
Yield 2025 *
3.63%
Free-Float 99.82%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.62%
1 week+0.33%
Current month-8.50%
1 month-4.73%
3 months-7.86%
6 months+13.32%
Current year-3.20%
More quotes
1 week
78.78
Extreme 78.78
81.34
1 month
78.43
Extreme 78.43
87.73
Current year
78.43
Extreme 78.43
89.18
1 year
68.84
Extreme 68.84
92.02
3 years
68.84
Extreme 68.84
135.89
5 years
68.84
Extreme 68.84
135.89
10 years
55.54
Extreme 55.54
135.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 26/15/26
Director of Finance/CFO 58 01/16/01
Chief Operating Officer 60 01/21/01
Members of the board TitleAgeSince
Director/Board Member 62 01/13/01
Director/Board Member 70 01/07/01
Director/Board Member 68 01/15/01
More insiders
Date Price Change Volume
26/24/26 79.74 +0.62% 5,024,880
25/24/25 79.25 -1.41% 5,624,078
24/24/24 80.38 -1.12% 5,028,857
23/24/23 81.29 +0.89% 5,296,230
22/24/22 80.57 +1.37% 4,962,583

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
79.74 USD
Average target price
94.75 USD
Spread / Average Target
+18.82%
Consensus